Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Vemurafenib plus rituximab bij refractaire of gerecidiveerde haarcelleukemie
aug 2021 | Leukemie